Could the mental health fallout of the pandemic spur growth in the healthcare sector?

Could the mental health fallout of the pandemic spur growth in the healthcare sector?

Charles Cathlin, the chief executive of TruGenomix - a private biotech company, spent the better half of the lockdown months trying to galvanise investors about the potential of his company to transform the treatment of post-traumatic stress disorder (PTSD). PTSD...

Continue reading →